Lanreotide Subcutaneous and Posaconazole Intravenous
Determining the interaction of Lanreotide Subcutaneous and Posaconazole Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Posaconazole Oral Suspension
- Lanreotide Subcutaneous-Posaconazole oral/injection
- Lanreotide Subcutaneous-Posaconazole Tablets
- Lanreotide Subcutaneous-PosiFlush flush
- Lanreotide Subcutaneous-Positive Skin Test Control - Histamine
- Lanreotide Subcutaneous-Posture
- Posaconazole Intravenous-Lansoprazole
- Posaconazole Intravenous-Lansoprazole Delayed-Release Capsules
- Posaconazole Intravenous-Lansoprazole Orally Disintegrating Tablets
- Posaconazole Intravenous-Lansoprazole, Amoxicillin, and Clarithromycin
- Posaconazole Intravenous-Lanthanum
- Posaconazole Intravenous-Lanthanum carbonate